Major review finds Alzheimer’s drugs provide little benefit
A large review concluded the drugs once promoted as a breakthrough for Alzheimer’s provide little meaningful benefit to patients, though some experts have disputed the analysis.
A major review released Thursday found that drugs once hailed as a breakthrough in treating Alzheimer’s disease do not meaningfully help patients. The conclusion has been met with criticism from some experts who questioned the review’s methods and findings.